Lexaria Bioscience (LEXX) News Today

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

$2.20

-0.05 (-2.22%)

(As of 04/19/2024 ET)

Source

Source	Headline
	Lexaria Bioscience, BioSig Technologies, BIMI Holdings among healthcare movers msn.com - April 17 at 12:49 PM
	Lexaria Bioscience Corp.: Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study finanznachrichten.de - April 16 at 11:09 AM
	Lexaria Bioscience Corp LEXX morningstar.com - April 5 at 11:50 PM
	Lexaria (NASDAQ: LEXX) Marks 2024 Milestone with FDA Clearance for Planned U.S. Phase 1b Hypertension Trial theglobeandmail.com - March 19 at 12:14 PM
	Lexaria Bioscience Revolutionizes Drug Delivery with DehydraTECH for GLP-1 drug proactiveinvestors.com - March 18 at 4:12 PM
	Lexaria Bioscience (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO theglobeandmail.com - March 15 at 9:26 PM
	Lexaria Bioscience Corp.: Lexaria Appoints Nelson Cabatuan as Chief Financial Officer finanznachrichten.de - March 14 at 10:51 AM
	Lexaria Bioscience Corp.: Lexaria Awards Contract For Next GLP-1 Human Pilot Study finanznachrichten.de - March 7 at 1:25 PM
	Lexaria to test DehydraTECH GLP-1 product for weight loss, diabetes msn.com - March 5 at 1:07 PM
	Lexaria Bioscience Corp.: 7% Weight Loss in Animals Supports Lexaria's Next 8-week Animal Study finanznachrichten.de - March 4 at 10:39 AM
	7% Weight Loss in Animals Supports Lexaria’s Next 8-week Animal Study finance.yahoo.com - March 4 at 10:39 AM
	Lexaria slips despite FDA nod to test blood pressure drug msn.com - March 1 at 7:05 PM
	This Lexaria Bioscience Insider Increased Their Holding By 23% Last Year finance.yahoo.com - February 18 at 12:37 PM
	Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - February 16 at 6:40 PM
	Lexaria Bioscience Corp.: Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules finanznachrichten.de - February 15 at 8:40 AM
	Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules finance.yahoo.com - February 15 at 8:40 AM
	Lexaria Bioscience’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Improves Delivery of GLP-1 Drug theglobeandmail.com - February 13 at 9:55 PM
	Lexaria Bioscience (NASDAQ: LEXX) To Hit High Ground in Q2/Q3 2024 with Animal, Human GLP-1 Studies theglobeandmail.com - January 30 at 1:59 PM
	Lexaria's Submits Investigational New Drug Application finance.yahoo.com - January 30 at 8:59 AM
	LEXX’ Sweet Opportunity in GLP-1s finance.yahoo.com - January 22 at 11:03 AM
	LEXX Stock Earnings: Lexaria Bioscience Reported Results for Q1 2024 investorplace.com - January 22 at 9:02 AM
	Lexaria Bioscience Corp.: Lexaria Unveils Extensive Planned 2024 GLP-1 Study Program finanznachrichten.de - January 16 at 12:00 PM
	Lexaria (NASDAQ: LEXX) Looking to Grow Revenue, Commercial Opportunities Through Licensing theglobeandmail.com - January 16 at 12:00 PM
	NetworkNewsWire: GLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons finanznachrichten.de - January 10 at 7:13 PM
	Lexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery, Efficacy of GLP-1 Agonists Through Proprietary Drug-Delivery Platform finance.yahoo.com - January 9 at 8:38 AM
	NetworkNewsWire: Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs finanznachrichten.de - January 8 at 9:49 AM
	Lexaria Bioscience Corp.: Lexaria's Patented Technology Improved the Oral Performance of the Rybelsus-Branded GLP-1 drug Semaglutide finanznachrichten.de - January 4 at 1:53 PM
	Lexaria Slides on New Drug Developments msn.com - January 4 at 1:53 PM
	Lexaria's Patented Technology Improved the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide finance.yahoo.com - January 4 at 1:53 PM
	Lexaria Bioscience Corp.: Lexaria's Investigational New Drug Application Filing Update finanznachrichten.de - December 7 at 10:08 AM
	Lexaria's Investigational New Drug Application Filing Update finance.yahoo.com - December 7 at 10:08 AM
	Lexaria Bioscience files to sell 1.62M for its holders seekingalpha.com - December 1 at 8:54 AM
	Lexaria (NASDAQ: LEXX) Tech Lowers Blood Glucose More Effectively than Semaglutide Alone theglobeandmail.com - November 28 at 8:13 PM
	Lexaria's Technology Improves the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide in Human Pilot Study benzinga.com - November 28 at 3:13 PM
	Lexaria's Technology Lowers Blood Glucose More Effectively than Rybelsus(R)-Branded GLP-1 drug Semaglutide Alone in Human Pilot Study finance.yahoo.com - November 28 at 10:12 AM
	Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs finance.yahoo.com - October 31 at 1:36 PM
	Lexaria Bioscience Corp.: Lexaria Granted Two New Patents in Canada finanznachrichten.de - October 12 at 12:42 PM
	Lexaria Granted Two New Patents in Canada finance.yahoo.com - October 12 at 12:42 PM
	Lexaria Bioscience’s (NASDAQ: LEXX) DehydraTECH(TM)-Nicotine Pouch Demonstrates Advantages over Competition theglobeandmail.com - October 4 at 12:13 AM
	Lexaria Bioscience enters into securities purchase agreement seekingalpha.com - October 1 at 7:54 PM
	Lexaria Bioscience Corp.: Lexaria Announces Pricing of $1.6 Million Registered Direct Offering finanznachrichten.de - September 29 at 9:22 AM
	Lexaria (NASDAQ: LEXX) to Demonstrate DehydraTECH-CBD Benefits in Upcoming IND Application theglobeandmail.com - September 23 at 7:34 AM
	Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, Alone or Together with DehydraTECH-CBD finance.yahoo.com - September 21 at 11:16 AM
	Lexaria Bioscience Corp.: Lexaria Provides Update on Investigational New Drug Application Progress finanznachrichten.de - August 30 at 10:00 AM
	Lexaria Provides Update on Investigational New Drug Application Progress finance.yahoo.com - August 30 at 10:00 AM
	LEXX: 3Q:23 Financial Results & Corporate Updates finance.yahoo.com - August 28 at 2:55 PM
	Lexaria Bioscience Corp.: Lexaria's DehydraTECH-Nicotine Faster than ZYN and on! finanznachrichten.de - August 9 at 11:08 AM
	Lexaria's DehydraTECH-Nicotine Faster than ZYN and on! finance.yahoo.com - August 9 at 11:08 AM
	Maxim Group Remains a Buy on Lexaria Bioscience (LEXX) markets.businessinsider.com - August 3 at 5:00 PM
	Lexaria Bioscience (LEXX) Price Target Decreased by 41.67% to 7.14 msn.com - August 3 at 5:00 PM

Get Lexaria Bioscience News Delivered to You Automatically

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

LEXX Media Mentions By Week

LEXX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LEXX
News Sentiment
▼
0.32

0.52
▲
Average
Medical
News Sentiment

LEXX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LEXX Articles
This Week
▼
2

1
▲
LEXX Articles
Average Week

Get Lexaria Bioscience News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:LEXX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lexaria Bioscience (LEXX) News Today

LEXX Media Mentions By Week

LEXX Media Sentiment

LEXX News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info